» Articles » PMID: 2728044

Protection from Cerebral Ischemia by Brain Cooling Without Reduced Lactate Accumulation in Dogs

Overview
Journal Stroke
Date 1989 Jun 1
PMID 2728044
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Hypothermia protects tissue function in ischemia. This study determined if selective brain cooling inhibits cerebral cortical lactate accumulation and thus accounts for imporved neurologic outcome after complete cerebral ischemia in dogs. The brain was selectively cooled (hippocampal temperature 33 degrees C) by nasal lavage with water at 5 degrees C. Control dogs received nasal lavage with water at 39 degrees C. Mean +/- SEM rectal temperature in both groups was 39 +/- 1 degree C prior to ischemia. Selective brain cooling before and during 10 minutes of cardiac arrest was associated with significantly improved neurologic function and 100% survival, whereas normothermic cardiac arrest produced marked neurologic dysfunction and 100% mortality. Cerebral cortical lactate accumulation was measured in a complementary series of dogs exposed to the same two treatments but with the addition of six cerebral cortical brain biopsies taken before, during, and immediately after cardiac arrest. Brain and rectal temperatures of dogs in the brain biopsy protocol were similar to those of dogs in the recovery protocol. There was no difference detected in cerebral lactate accumulation during ischemia between brain-cooled and control dogs. Thus, reduction in cortical brain lactate during ischemia cannot account for the postischemic functional protection afforded by preischemic selective brain cooling.

Citing Articles

Outcome and current status of therapeutic hypothermia after out-of-hospital cardiac arrest in Korea using data from the Korea Hypothermia Network registry.

Lee B, Park K, Kang G, Kim K, Kim G, Kim W Clin Exp Emerg Med. 2014; 1(1):19-27.

PMID: 27752548 PMC: 5052822. DOI: 10.15441/ceem.14.007.


Changes of c-fos, malondialdehyde and lactate in brain tissue after global cerebral ischemia under different brain temperatures.

Zhang H, Li L, Xu G, Mei Y, Zhang J, Murong S J Huazhong Univ Sci Technolog Med Sci. 2014; 34(3):354-358.

PMID: 24939298 DOI: 10.1007/s11596-014-1282-4.


[Successful treatment of extreme metabolic acidosis and profound hypothermia].

Neuenfeldt T, Hopf H Anaesthesist. 2009; 58(11):1113-8.

PMID: 19756334 DOI: 10.1007/s00101-009-1615-z.


The TOBY Study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: a randomised controlled trial.

Azzopardi D, Brocklehurst P, Edwards D, Halliday H, Levene M, Thoresen M BMC Pediatr. 2008; 8:17.

PMID: 18447921 PMC: 2409316. DOI: 10.1186/1471-2431-8-17.


Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1: Indications and evidence.

Polderman K Intensive Care Med. 2004; 30(4):556-75.

PMID: 14767591 DOI: 10.1007/s00134-003-2152-x.